A pharmacy benefit carve-out is when a plan sponsor separates its prescription drug benefits from its medical insurance carrier and contracts directly with a pharmacy benefit manager. The alternative, letting the medical insurance carrier provide pharmacy benefits as part of the bundled medical plan, is called a carve-in.
The carve-out vs carve-in decision is one of the highest-leverage choices a self-insured plan sponsor can make. For mid-size and larger plans, a well-executed carve-out typically saves 10–25% on pharmacy spend. For smaller plans, the savings often don't justify the operational complexity.
Carve-out vs carve-in in one paragraph
In a carve-in, the medical insurance carrier (Aetna, BCBS, UnitedHealthcare, etc.) provides both medical and pharmacy benefits under a single bundled contract. The pharmacy benefit is typically administered by the carrier's owned or partner PBM, with pricing and contract terms set by the carrier rather than negotiated separately by the plan. In a carve-out, the plan signs a separate, direct contract with a PBM of its choice. The medical carrier handles only medical claims; the PBM handles pharmacy. The plan gets to negotiate pharmacy terms independently and switch PBMs separately from switching medical carriers.
Why most plans are still carved in
Despite the financial case for carve-outs, most plans are still carved in. Three reasons:
1. Default state. When a plan sponsor first goes self-insured, the medical carrier typically defaults to bundling pharmacy in unless explicitly told not to. Inertia keeps the bundling in place at renewal.
2. Marketing. Medical carriers actively market the "integration benefits" of carved-in pharmacy, the idea that medical and pharmacy data sharing improves care coordination. The clinical claim has some merit; the financial claim usually doesn't.
3. Perceived complexity. Plan sponsors believe carving out is hard. It's actually not, a well-managed carve-out implementation is a 8–12 week project, but the perception persists.
What you gain with a carve-out
1. Pricing transparency. A direct PBM contract lets you negotiate pass-through pricing. Carried-in pharmacy is almost always traditional/spread pricing because the carrier controls the contract.
2. Contract leverage. A direct contract means you can compete the PBM market every 2–3 years. Bundled pharmacy means the PBM is locked to the medical carrier, you can only "change PBMs" by changing medical carriers.
3. Specialty pharmacy choice. A direct PBM contract lets you negotiate specialty pharmacy access. Carried-in pharmacy typically forces members through the carrier's owned specialty pharmacy.
What you give up with a carve-out
1. Medical-pharmacy data integration. When the same vendor handles medical and pharmacy, the data is integrated by default. With a carve-out, you have to actively coordinate data sharing between the medical carrier and the PBM.
2. Single point of contact. Carved-in plans have one account team for medical and pharmacy. Carved-out plans have two.
3. Specialty step therapy across benefit types. Some specialty drugs are paid under medical benefit versus pharmacy benefit. When medical and pharmacy are with different vendors, coordinating step therapy across both benefit types requires more deliberate setup.
These tradeoffs are real but usually small relative to the financial gains.
The carve-out process step by step
A typical carve-out implementation runs 8–12 weeks:
Weeks 1–2: RFP and PBM selection. Issue a structured RFP to 4–6 PBMs (including a mix of Big 3 and transparent independents). Score responses on pricing, services, network, technology, and references. Select 2 finalists.
Weeks 3–4: Finalist negotiation. Negotiate contract terms with finalists. This is where the contract clauses matter, pass-through structure, audit rights, MAC transparency, rebate methodology.
Weeks 5–6: Final selection and contract execution. Choose the winning PBM. Execute the contract. Notify the incumbent of the carve-out effective date.
Weeks 7–10: Implementation. Member communication. Eligibility file transfer. Pharmacy network setup. Mail-order and specialty pharmacy member migration. Customer service team training.
Weeks 11–12: Go-live. Effective date, typically January 1 or another natural plan-year start. Real-time monitoring during the first 30 days for member experience issues.
The most common implementation pitfall: rushing the member communication. Three weeks of advance member communication is the minimum.
Common carve-out pitfalls
1. Specialty pharmacy disruption. Members on chronic specialty therapies need active outreach 30+ days before transition.
2. Mail-order migration. Members on auto-refill mail-order need to actively re-enroll with the new PBM's mail-order pharmacy.
3. Prior authorization records. PA approvals from the old PBM don't automatically transfer.
4. Network gaps. Some retail pharmacies are in some networks but not others.
5. Stop-loss coordination. If the plan has pharmacy stop-loss coverage, the stop-loss carrier needs to be notified.
A good consultant manages all five of these proactively.
When carve-in is still the right answer
1. Very small plans (under 200 lives). PBMs typically don't quote competitive direct contracts below 200 lives.
2. Plans heavily reliant on medical-pharmacy integration. Some employer wellness or disease management programs depend on integrated medical-pharmacy data.
3. Plans with very low pharmacy spend. A plan where pharmacy is less than 10% of total benefit spend may not save enough from a carve-out.
For most plans 500 lives and up with normal pharmacy spend, carve-out is the right answer.
The takeaway
Pharmacy benefit carve-outs deliver real, durable savings for plans large enough to benefit from direct PBM contracting. For mid-size and larger self-insured plans, carve-out is the structural baseline; carve-in is the exception.